Skip to main content

Table 4 Total healthcare cost per month by baseline phosphate, Hungary, Italy, Portugal, Spain, and Turkey

From: Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study

  Baseline phosphate*, mmol/mL Total
< 1.13 ≥ 1.13 – ≤ 1.78 > 1.78 Missing  
N patients 827 3104 1208 247 5386
Total cost per month (including patients with zero costs), 2006 €
  Mean 62.02 75.27 88.88 66.60 75.89
  SD 176.01 273.40 145.08 147.07 231.52
  Median 15.24 26.66 46.00 28.57 28.61
  Q1, Q3 4.48, 54.32 8.51, 82.41 14.49, 107.77 10.65, 72.60 8.55, 83.69
  Min, Max 0.00, 3790.69 0.00, 9533.54 0.00, 2031.16 0.00, 1766.00 0.00, 9533.54
Patients with cost per month > €0, n (%) 732 (89) 2856 (92) 1116 (92) 234 (95) 4938 (92)
Cost of hospitalisations per month (including patients with zero costs), 2006 €
  Mean 24.81 22.53 17.87 25.05 21.95
  SD 165.02 264.57 111.07 142.43 219.56
  Median 0.00 0.00 0.00 0.00 0.00
  Q1, Q3 0.00, 0.00 0.00, 0.00 0.00, 0.00 0.00, 0.00 0.00, 0.00
  Min, Max 0.00, 3790.69 0.00, 9533.54 0.00, 1879.98 0.00, 1766.00 0.00, 9533.54
Patients with hospitalisation cost per month > €0, n (%) 50 (6) 130 (4) 60 (5) 14 (6) 254 (5)
Cost of medications per month (including patients with zero costs), 2006 €
  Mean 37.21 52.74 71.01 41.55 53.94
  SD 60.95 69.83 87.04 44.81 72.70
  Median 13.45 24.96 41.28 27.11 26.02
  Q1, Q3 3.89, 45.32 8.12, 74.40 13.37, 95.17 10.57, 62.62 8.04, 74.56
  Min, Max 0.00, 549.78 0.00, 709.97 0.00, 676.07 0.00, 365.41 0.00, 709.97
Patients with medication cost per month > €0, n (%) 727 (88) 2848 (92) 1112 (92) 233 (94) 4920 (91)
  1. *Mean phosphate during 3-month baseline period.